-transparent.png){kind=logo}
Two severe combined-immunodeficiency patients successfully transplanted with fetal thymus and liver or haploidentical lectin-treated marrow cells lacked NK activity, with a normal number of HNK1+ cell-defined NK cells. The defect was not due to the inhibiting factor in patients' sera. Their NK cells bound to their targets, but did not lyse them in a single-cell agarose assay, and did not respond to alpha-IFN or IL-2. IL-2 did not stimulated the development of mature NK cells that bear M1 antigens from precursors that lack M1 antigens.
Related Publications
Y I Gotoh, and
Y Yamaguchi, and
M Minegishi, and
T Konno, and
K Tada
November 1985,
Journal of clinical immunology,
Y I Gotoh, and
Y Yamaguchi, and
M Minegishi, and
T Konno, and
K Tada
March 1979,
Transplantation proceedings,
Y I Gotoh, and
Y Yamaguchi, and
M Minegishi, and
T Konno, and
K Tada
October 1993,
Seminars in hematology,
Y I Gotoh, and
Y Yamaguchi, and
M Minegishi, and
T Konno, and
K Tada
April 1984,
Lancet (London, England),
Y I Gotoh, and
Y Yamaguchi, and
M Minegishi, and
T Konno, and
K Tada
January 1982,
Immunology letters,
Y I Gotoh, and
Y Yamaguchi, and
M Minegishi, and
T Konno, and
K Tada
April 2019,
The Journal of allergy and clinical immunology,
Y I Gotoh, and
Y Yamaguchi, and
M Minegishi, and
T Konno, and
K Tada
January 1976,
Scandinavian journal of immunology,
Y I Gotoh, and
Y Yamaguchi, and
M Minegishi, and
T Konno, and
K Tada
February 2011,
Hematology/oncology clinics of North America,
Y I Gotoh, and
Y Yamaguchi, and
M Minegishi, and
T Konno, and
K Tada
February 2010,
Immunology and allergy clinics of North America,
Y I Gotoh, and
Y Yamaguchi, and
M Minegishi, and
T Konno, and
K Tada
January 1983,
Birth defects original article series,
